Hi ashleywd, I think it may be wise to re-base your P/E based on the information released to market today with provision accounted for. I would suggest that provisions are not taken up for no reason - and the tax-man will certainly make sure of this too. Normalised EPS of 0.92 cents for period to 31 Dec 2015. Forecast EBITDA of 25.8m. I assume that we will see an EPS for FY16 of closer to ~9.5 cents. With this figure in mind, rather than applying the current ttm EPS, we see a P/E of 7.57. Applying the x12 ratio mentioned above, the "fair value" SP is closer to $1.14. This somewhat agrees with the valuation provided by accaeric. Perhaps at this stage there is an element of risk priced in with net debt ratio now at 18.3% - not massive by any means, but need the cash-flow to balance this. My thoughts only, welcome a good discussion.
- Forums
- ASX - By Stock
- SHJ
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-42
Featured News
Add SHJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
87.0¢ |
Change
0.020(2.35%) |
Mkt cap ! $150.5M |
Open | High | Low | Value | Volume |
85.0¢ | 87.0¢ | 85.0¢ | $64.74K | 75.28K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 31801 | 86.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.0¢ | 9837 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31801 | 0.860 |
1 | 4264 | 0.850 |
1 | 10000 | 0.810 |
2 | 3474 | 0.800 |
2 | 1948 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.870 | 9837 | 1 |
0.880 | 4869 | 2 |
0.900 | 25332 | 2 |
0.910 | 20680 | 2 |
0.955 | 6045 | 2 |
Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
Featured News
SHJ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online